Figure 5 | Laboratory Investigation

Figure 5

From: Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4+Foxp3+ T cells in concordant heart transplantation

Figure 5

IL-33+Lef treatment changes cytokine expression of xenograft recipients in splenocytes. On day 2 and day 7, levels of IL-4, IL-10, IFN-γ, and TGF-β in the supernatants from the MLR assay (a,b) and serum (c,d) were detected by using commercially available ELISA kits. Each reaction was carried out in triplicate. (*P<0.05, **P<0.01, ***P<0.001; ^P<0.05, ^^P<0.01, ^^^P<0.001, *means each group was compared to the control group; ^means each group was compared with each other in exclusion of the control group).

Back to article page